Clinical Trial Update: Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Targeting Vascular Inflammation in Patients with Community-Acquired Pneumonia; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Community-acquired Pneumonia

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Inflammation, Community Acquired Pneumonia (CAP) | Phase 3 | Status: NOT_YET_RECRUITING